Effect of noncompetitive proteasome inhibition on bortezomib resistance (Q33588424)

28 July 2017

Effect of noncompetitive proteasome inhibition on bortezomib resistance (English)

1 reference

28 July 2017

10

Hans Adomat

0 references

Emma Guns

20

Emma Guns

0 references

Lewis E. Kay

22

Lewis E Kay

1 reference

28 July 2017

Robert A Batey

21

0 references

Aaron Schimmer

Aaron D Schimmer

23

0 references

Suzanne Trudel

12

Suzanne Trudel

1 reference

28 July 2017

17

Jacqueline Cloos

1 reference

28 July 2017

Xiaoming Li

1

1 reference

28 July 2017

Tabitha E Wood

2

1 reference

28 July 2017

Remco Sprangers

3

1 reference

28 July 2017

Gerrit Jansen

4

1 reference

28 July 2017

Niels E Franke

5

1 reference

28 July 2017

Xinliang Mao

6

1 reference

28 July 2017

Xiaoming Wang

7

1 reference

28 July 2017

Yi Zhang

8

1 reference

28 July 2017

Sue Ellen Verbrugge

9

1 reference

28 July 2017

Hans Adomat

10

1 reference

28 July 2017

Zhi Hua Li

11

1 reference

28 July 2017

Christine Chen

13

1 reference

28 July 2017

Tomasz L Religa

14

1 reference

28 July 2017

Nazir Jamal

15

1 reference

28 July 2017

Hans Messner

16

1 reference

28 July 2017

David R Rose

18

1 reference

28 July 2017

Ami Navon

19

1 reference

28 July 2017

Emma Guns

20

1 reference

28 July 2017

language of work or name

English

0 references

publication date

26 May 2010

1 reference

Journal of the National Cancer Institute

28 July 2017

1 reference

28 July 2017

102

1 reference

28 July 2017

14

1 reference

28 July 2017

1069-1082

1 reference

Protein degradation and protection against misfolded or damaged proteins

28 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Drug discovery in the ubiquitin-proteasome system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Getting into position: the catalytic mechanisms of protein ubiquitylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Crystal structures of Salinosporamide A (NPI-0052) and B (NPI-0047) in complex with the 20S proteasome reveal important consequences of beta-lactone ring opening and a mechanism for irreversible binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Mechanisms of proteasome inhibitor action and resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

TROSY-based NMR evidence for a novel class of 20S proteasome inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Inhibition of the sodium/potassium ATPase impairs N-glycan expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

NMRPipe: a multidimensional spectral processing system based on UNIX pipes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Cloning and sequencing of the gene encoding the large (alpha-) subunit of the proteasome from Thermoplasma acidophilum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Bortezomib activity and in vitro interactions with anthracyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Development of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Acquired resistance of human T cells to sulfasalazine: stability of the resistant phenotype and sensitivity to non-related DMARDs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Acquired resistance to chloroquine in human CEM T cells is mediated by multidrug resistance-associated protein 1 and provokes high levels of cross-resistance to glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Phase I study of bortezomib in refractory or relapsed acute leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Proline- and arginine-rich peptides constitute a novel class of allosteric inhibitors of proteasome activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

A robust and cost-effective method for the production of Val, Leu, Ile (delta 1) methyl-protonated 15N-, 13C-, 2H-labeled proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

Quantitative dynamics and binding studies of the 20S proteasome by NMR

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ198

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJQ198

1 reference

28 July 2017

1 reference